Biosite Announces Presentation at Nasdaq's 17th Annual Investor Program
June 16 2006 - 3:00PM
PR Newswire (US)
SAN DIEGO, June 16 /PRNewswire-FirstCall/ -- Biosite Incorporated
(NASDAQ:BSTE) today announced that Gunars Valkirs, Ph.D, senior
vice president, Biosite Discovery, will discuss the Company's
operating environment, products and research and development
activities at Nasdaq's 17th Annual Investor Program. The conference
will be held at the Renaissance Chancery Court in London. Biosite's
presentation will take place June 21, 2006, at 4:30 p.m. Greenwich
Mean Time. A link to the live audio webcast can be accessed through
the Biosite website, http://www.biosite.com/. The Biosite
presentation will be archived on the website until July 12, 2006 in
the Investor Center under Events Calendar. About Biosite
Incorporated Biosite Incorporated is a leading bio-medical company
commercializing proteomics discoveries for the advancement of
medical diagnosis. The Company's products contribute to
improvements in medical care by aiding physicians in the diagnosis
of critical diseases and health conditions. Biosite's Triage(R)
rapid diagnostics are used in approximately 50 percent of U.S.
hospitals and in more than 60 international markets. Information on
Biosite can be found at http://www.biosite.com/. Biosite(R),
Triage(R) and New Dimensions in Diagnosis(R) are registered
trademarks of Biosite Incorporated. The Company's logo is a
trademark of Biosite Incorporated. DATASOURCE: Biosite Incorporated
CONTACT: Nadine Padilla, Vice President, Corporate and Investor
Relations of Biosite Incorporated, +1-858-805-2820, Web site:
http://www.biosite.com/ Company News On-Call:
http://www.prnewswire.com/comp/116737.html
Copyright
Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jul 2023 to Jul 2024